DGNS logo

PT Diagnos Laboratorium Utama Tbk Stock Price

IDX:DGNS Community·Rp360.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

DGNS Share Price Performance

Rp288.00
125.00 (76.69%)
Rp288.00
125.00 (76.69%)
Price Rp288.00

DGNS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with questionable track record.

2 Risks
1 Reward

PT Diagnos Laboratorium Utama Tbk Key Details

Rp171.1b

Revenue

Rp89.3b

Cost of Revenue

Rp81.7b

Gross Profit

Rp78.4b

Other Expenses

Rp3.3b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
2.68
47.77%
1.96%
27.4%
View Full Analysis

About DGNS

Founded
2007
Employees
81
CEO
Fergus Richard
WebsiteView website
diagnos.co.id

PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers laboratory tests comprising hemostasis, hepatitis, autoimmune and rheumatology, tumor markers, toxicology, lipid, allergies, TORCH, diabetes, electrolytes-blood gases, respiratory tract infection, pathology anatomy, neonatal screening, hematology, body fluids, feces, specific proteins, DNAnswer genomics, kidney function, liver function, immunology, osteoporosis, thyroid, pharmacogenomic, heart, reproduction and fertility, microbiology, drug monitoring, lungs, gastrointestinal, nutrition and heavy metals, anemia, and other bacteria; genomics; homecare services; and inspection panel tests. It also provides clinical pathology, anatomical pathology, and microbiology laboratory; and corporate health and research services. PT Diagnos Laboratorium Utama Tbk was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.

Recent DGNS News & Updates

Recent updates

No updates